Summary
94.83
0.11
(0.12%)
08/13/2026
CVS Health Corp. (CVS)Key Facts
Performance
Historical returns1D
0.12%
1W
-1.56%
1M
-10.00%
3M
0.16%
6M
23.37%
1Y
49.17%
5Y
31.26%
Snapshot
Key statisticsClose
94.83
Change
0.11
Change %
0.12%
Open
95.44
Day Range
94.49 – 96.12
Volume
3,670,623
Avg Vol (20d)
8,180,128
Rel Vol
0.45x
52W Range
63.26 - 110.00
vs 52W High
-13.79%
vs 52W Low
49.91%
Gap
-2.61
Market Cap
USD 98.53B
Beta
0.48
Dividend Yield
4.77%
Price Chart
Advanced chartCompareLast 730 data points are shown. To view all data, Upgrade to PRO plan!
Notable Price Movement
Historical returnsAug 13
2026
$94.83 0.12%Latest
CVS Health rose 0.12% to $94.83, though on light volume (0.4× the 20-day average). Shares opened with a 0.76% gap up. The move added $138.1M of market value and left the stock 13.7% below its 52-week high.
Aug 6
2026
$96.22 2.93%Earnings
CVS Health fell 2.93% to $96.22, a 1.7σ move against its 60-day volatility. This was largely stock-specific: the S&P 500 fell 0.16% while Healthcare peers (XLV) rose 0.18% that session, leaving about 2.8 points of the move unexplained by the market after adjusting for a 0.48 beta. Shares opened with a 1.88% gap up and reversed through the session, closed near the session low (2% of the day's range) and marked a 3rd consecutive decline. It came 1 session after the quarterly print. The move erased $3.64B of market value.
Aug 5
2026
$99.12 5.08%Earnings
CVS Health fell 5.08% to $99.12, its biggest one-day drop in 6 months and a 3.1σ move against its 60-day volatility, on 2.4× average volume. This was largely stock-specific: the S&P 500 fell 0.20% while Healthcare peers (XLV) rose 1.27% that session, leaving about 5.0 points of the move unexplained by the market after adjusting for a 0.48 beta. Shares opened with a 10.25% gap down and lost their 50-day moving average. This was the first session after quarterly results: EPS of $2.58 vs $1.87 expected (a beat) and revenue of $106.10B vs $100.03B (a beat). The move erased $6.65B of market value. Historically, after 2.5σ-or-larger down days, CVS Health returned +0.79% on average over the following 5 sessions (46% positive, n=13).
Aug 3
2026
$105.37 0.90%Earnings
CVS Health rose 0.90% to $105.37. Shares opened with a 0.89% gap up. It came 2 sessions after the Q2 2026 print. The move added $1.18B of market value.
Jul 30
2026
$105.22 0.66%Earnings
CVS Health fell 0.66% to $105.22. Shares opened with a 0.87% gap down, closed near the session high (89% of the day's range) and lost their 20-day moving average. This was the first session after Q2 2026 results. The move erased $878.8M of market value.
Jul 21
2026
$109.92 2.78%52W High
CVS Health rose 2.78% to $109.92, its biggest one-day gain in 4 weeks. This was largely stock-specific: the S&P 500 gained 0.83% while Healthcare peers (XLV) rose 0.63% that session, leaving about 2.1 points of the move unexplained by its sector. Shares closed near the session high (99% of the day's range), set a 52-week closing high and marked a 4th consecutive advance. The move added $3.73B of market value.
Computed from adjusted closes over the last 22 sessions; attribution vs SPY and XLV.
New Highs
Historical highs| Period | New Highs | From Last |
|---|---|---|
| 5-Day | 1× | -0.88% |
| 1-Month | 3× | -13.73% |
| 3-Month | 11× | -13.73% |
| 6-Month | 21× | -13.73% |
| YTD | 24× | -13.73% |
| Period | New Highs | From Last |
|---|---|---|
| 52-Week | 45× | -13.73% |
| 2-Year | 65× | -13.73% |
| 3-Year | 43× | -13.73% |
| 5-Year | 45× | -13.73% |
| 10-Year | 41× | -13.73% |
Financial SnapshotFY 2025
Full financialsRevenue
USD 402.07B
+7.8% YoY
Net Income
USD 1.73B
-62.3% YoY
EPS
1.40
-61.7% YoY
Gross Margin
13.8%
Operating Margin
2.6%
Net Margin
0.4%
EBITDA
USD 9.86B
Free Cash Flow
USD 7.81B
1.9% margin
ROE
2.3%
ROA
0.7%
Debt / Equity
1.24x
net debt USD 85.08B
Cash & Equiv.
USD 8.51B
Fundamental Ratings
MainB+
RecommendedNeutral
DCFStrong Buy
ROENeutral
ROANeutral
Debt/EquityStrong Sell
P/ESell
P/BBuy
Latest Earnings
- CVS reported last earnings on 2026-08-05.
- EPS of $2.58 vs $1.87 estimated — surprise $0.71.
- Revenue of $106,096M vs $100,028M estimated — surprise $6,068M.
News
All newsNew study from CVS Caremark and Employee Benefit News shows how employers rely on their pharmacy benefit manager to create sustainable pharmacy solutions
Key opportunities include: managing GLP-1s, encouraging biosimilar substitution and employing technology to simplify and personalize the member experience WOONSOCKET, R.I., Aug. 12, 2026 /PRNewswire/ -- CVS Caremark, part of CVS Health® (NYSE: CVS), today announced the findings of a survey...
E. Ohman J or Asset Management AB Decreases Holdings in CVS Health Corporation $CVS
E. Ohman J or Asset Management AB lowered its position in CVS Health Corporation (NYSE: CVS) by 30.2% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,455 shares of the...
Richard Pzena Buys LKQ Corp (LKQ) -- Shares Look 38% Undervalued on GF Value
On June 30, 2026, Richard Pzena (Trades, Portfolio)'s firm executed a significant addition to its existing position in LKQ Corp (LKQ, Financial), purchasing 9,1
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie leverages a strong specialty drug portfolio to offset the loss of exclusivity for its former top-selling products. CVS Health continues to expand its integrated healthcare model through its massive insurance and pharmacy network.
Here's Why CVS Health (CVS) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
CVS Health: I Wanted A Beat And Raise, I Got It, And I'm Still At 'Hold'
CVS Health Corporation's strong Q2 results delivered revenue and earnings beats while management raised operating cash flow guidance to $11.5 billion. Aetna turnaround and improved medical benefit ratios boosted first half cash generation, helping drive recent stock gains. Management anticipates...
Broad Market Momentum & Defensive Pivots: This Week's Top ETF Flows
The ETF market saw a massive surge into core index heavyweights this past week, as investors poured billions into broad U.S. equities and mega-cap tech leadership. However, this aggressive accumulation was paired with deliberate defensive positioning in ultra-short Treasuries, spot gold, and...
CVS Q2 Earnings Call Pairs Aetna Recovery With 2027 PBM Risks
CVS Health lifts its 2026 outlook on Aetna's recovery and retail strength while flagging 2027 pressure from 340B changes and Caremark membership declines.
Medicare Made Weight-Loss Drugs $50 A Month—Now Amazon, CVS And Walmart Race To Fill Prescriptions
More than 66 million. That's how many people in the U.S. get their health coverage from Medicare, according to the insurance program.
CVS Health Q2 Earnings Call Highlights
CVS Health NYSE: CVS reported second-quarter results that exceeded its expectations, citing earnings growth across all operating segments and raising its full-year outlook for adjusted earnings per share and operating cash flow.
3 Medical Stocks Standing Out After Crushing Q2 Earnings Expectations
As investors look to balance growth opportunities with defensive positioning, Acadia Pharmaceuticals, CVS Health, and Eli Lilly stand out as healthcare names combining resilient business models with strong earnings momentum.
CVS Health Corp (CVS) (Q2 2026) Earnings Call Highlights: Strong Earnings Beat and Raised Guidance Signal Accelerating Turnaround
Revenue: Over $106 billion in Q2 2026, an increase of over 7% year-over-year.Adjusted Operating Income: Approximately $5.2 billion, up 35% from the prior year q
CVS Stock Drops 5.8% as 2027 Outlook Disappoints
CVS Health (CVS), a healthcare giant spanning insurance, pharmacy-benefit management and retail pharmacies, delivered another strong quarter on Wednesday, but W
CVS Health Corporation (CVS) Q2 2026 Earnings Call Transcript
CVS Health Corporation (CVS) Q2 2026 Earnings Call Transcript
ADP Cools to +44K, Earnings Show Beats from DIS, LLY & More
Today's ADP private-sector payrolls came in below the +75K forecast and less than half the downwardly revised +95K from June.
CVS Health Q2 Earnings and Revenues Top Estimates, Stock Climbs
CVS beats Q2 earnings and revenue estimates as stronger segment performance lifts results and prompts raised 2026 guidance, sending shares higher.
CVS Health tops second-quarter estimates, raises full-year profit outlook
CVS Health Corp (NYSE:CVS) reported second-quarter revenue and profit that beat Wall Street estimates on Wednesday, and raised its full-year adjusted earnings guidance, though cautious guidance pressured shares. Revenue rose 7.3% year-over-year to $106.1 billion, above analyst estimates of $100.11...
Here's Why CVS Health (CVS) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CVS Health (CVS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for CVS Health (CVS) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CVS Health (CVS) Q2 Earnings and Revenues Beat Estimates
CVS Health (CVS) came out with quarterly earnings of $2.58 per share, beating the Zacks Consensus Estimate of $1.87 per share. This compares to earnings of $1.81 per share a year ago.